| 000 | 01674 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250513055855.0 | ||
| 264 | 0 | _c19940908 | |
| 008 | 199409s 0 0 eng d | ||
| 022 | _a0003-4819 | ||
| 024 | 7 |
_a10.7326/0003-4819-121-6-199409150-00005 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMarroni, M | |
| 245 | 0 | 0 |
_aInterferon-alpha is effective in the treatment of HIV-1-related, severe, zidovudine-resistant thrombocytopenia. A prospective, placebo-controlled, double-blind trial. _h[electronic resource] |
| 260 |
_bAnnals of internal medicine _cSep 1994 |
||
| 300 |
_a423-9 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAcquired Immunodeficiency Syndrome _xcomplications |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aBleeding Time |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHIV-1 |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInterferon-alpha _xadverse effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aPlatelet Count |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 |
_aThrombocytopenia _xblood |
| 650 | 0 | 4 |
_aZidovudine _xtherapeutic use |
| 700 | 1 | _aGresele, P | |
| 700 | 1 | _aLandonio, G | |
| 700 | 1 | _aLazzarin, A | |
| 700 | 1 | _aCoen, M | |
| 700 | 1 | _aVezza, R | |
| 700 | 1 | _aSinnone, M S | |
| 700 | 1 | _aBoschetti, E | |
| 700 | 1 | _aNosari, A M | |
| 700 | 1 | _aStagni, G | |
| 700 | 1 | _aNenci, G G | |
| 700 | 1 | _aPauluzzi, S | |
| 773 | 0 |
_tAnnals of internal medicine _gvol. 121 _gno. 6 _gp. 423-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.7326/0003-4819-121-6-199409150-00005 _zAvailable from publisher's website |
| 999 |
_c8052943 _d8052943 |
||